Laura Nsangi

Oral Lipid Nanocrystal Amphotericin B for Cryptococcal Meningitis: A Randomized Clinical Trial

David R. Boulware, Mucunguzi Atukunda, Enock Kagimu et al. · Clinical Infectious Diseases · 2023 · 64 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +15

Cost-effectiveness of single, high-dose, liposomal amphotericin regimen for HIV-associated cryptococcal meningitis in five countries in sub-Saharan Africa: an economic analysis of the AMBITION-cm trial

David S. Lawrence, Charles Muthoga, David B. Meya et al. · The Lancet Global Health · 2022 · 30 citations · Full text

Pharmacy, Infectious Diseases, Pharmacoeconomics +17

Therapeutic Lumbar Punctures in Human Immunodeficiency Virus–Associated Cryptococcal Meningitis: Should Opening Pressure Direct Management?

Enock Kagimu, Nicole Engen, Kenneth Ssebambulidde et al. · Open Forum Infectious Diseases · 2022 · 21 citations · Full text

Medicine, Infectious Diseases, Neurology +13

Development and validation of quantitative PCR assays for HIV-associated cryptococcal meningitis in sub-Saharan Africa: a diagnostic accuracy study

Tshepiso Mbangiwa, Aude Sturny-Leclère, Kwana Lechiile et al. · The Lancet Microbe · 2024 · 16 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +17

Implementation of accelerated research: strategies for implementation as applied in a phase 1 Ad26.ZEBOV, MVA-BN-Filo two-dose Ebola vaccine clinical trial in Uganda

Jonathan Kitonsa, Abu-Baker Ggayi, Zacchaeus Anywaine et al. · Global Health Action · 2020 · 13 citations · Full text

Veterinary Medicine, Infectious Diseases, Preventive Medicine +17